Adverum Biotechnologies, Inc. (ADVM)
NASDAQ: ADVM · Real-Time Price · USD
2.710
-0.100 (-3.56%)
At close: May 12, 2025, 4:00 PM
2.760
+0.050 (1.85%)
After-hours: May 12, 2025, 7:48 PM EDT
Adverum Biotechnologies Market Cap
Adverum Biotechnologies has a market cap or net worth of $56.61 million as of May 12, 2025. Its market cap has decreased by -73.23% in one year.
Market Cap
56.61M
Enterprise Value
24.30M
1-Year Change
-73.23%
Ranking
Category
Stock Price
$2.71
Market Cap Chart
Since July 31, 2014, Adverum Biotechnologies's market cap has decreased from $581.50M to $56.61M, a decrease of -90.26%. That is a compound annual growth rate of -19.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 58.70M | -39.55% |
| Dec 31, 2024 | 97.10M | 27.60% |
| Dec 29, 2023 | 76.10M | 31.66% |
| Dec 30, 2022 | 57.80M | -66.53% |
| Dec 31, 2021 | 172.70M | -83.66% |
| Dec 31, 2020 | 1.06B | 42.01% |
| Dec 31, 2019 | 744.10M | 275.81% |
| Dec 31, 2018 | 198.00M | 25.63% |
| Dec 29, 2017 | 157.60M | 30.25% |
| Dec 30, 2016 | 121.00M | -50.65% |
| Dec 31, 2015 | 245.20M | -79.79% |
| Dec 31, 2014 | 1.21B | 108.67% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.08B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |